Posizioni attive di Sara Blum Sherman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| EXSCIENTIA PLC | Contatto Relazioni con gli Investitori | 01/08/2021 | - |
Exscientia AI Ltd.
 Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Contatto Relazioni con gli Investitori | - | - |
Storia della carriera di Sara Blum Sherman
Precedenti posizioni note di Sara Blum Sherman
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| UROGEN PHARMA LTD. | Contatto Relazioni con gli Investitori | - | 01/08/2021 |
| DBV TECHNOLOGIES | Public Communications Contact | 01/08/2016 | 01/09/2020 |
Statistiche
Distribuzione geografica
| Regno Unito | 3 |
| Francia | 2 |
| Stati Uniti | 2 |
Posizioni
| Investor Relations Contact | 3 |
| Public Communications Contact | 1 |
Settori
| Health Technology | 5 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| DBV TECHNOLOGIES | Health Technology |
| UROGEN PHARMA LTD. | Health Technology |
| EXSCIENTIA PLC | Health Technology |
| Aziende private | 1 |
|---|---|
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Sara Blum Sherman
- Esperienza
